Impact of the Introduction of Bispecifics on the Management of Multiple Myeloma

by | May 9, 2024 | Myeloma News | 0 comments

Source: Pharmacy Times articles

Ke Ning, MD, discusses the impact of the introduction of bispecific antibodies for treating patients with relapsed or refractory multiple myeloma.
Read More

Submit a Comment